Previous 10 | Next 10 |
AMGEN OPENS STATE-OF-THE-ART BIOMANUFACTURING SITE IN CENTRAL OHIO PR Newswire THOUSAND OAKS, Calif. , Feb. 26, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the opening of its manufacturing site in Central Ohio , the newest in its global oper...
2024-02-22 21:53:11 ET Amgen Inc. (AMGN) Amgen Meeting on Rare Disease February 22, 2024 04:00 PM ET Company Participants Justin Claeys - Vice President of Investor Relations Murdo Gordon - EVP, Global Commercial Operations Vikram Karnani - Executive, Rare Diseas...
2024-02-22 14:41:34 ET More on Amgen, Eli Lilly, etc. Pfizer's Post-Pandemic Pivot Pfizer: Turnaround Is Gaining Momentum Eli Lilly: Yes, It Is Too Late To Join The Party Novo to face Wegovy competition in India as local versions loom: Reuters Weight-...
2024-02-21 07:13:01 ET Regeneron ( NASDAQ: REGN ) and Vertex Pharmaceuticals ( NASDAQ: VRTX ) have crossed $100B in market capitalization for the first time, joining two other giants in the biotech industry, Amgen ( AMGN ) and AbbVie ( ABBV ).... Read the full ...
AMGEN TO HOST CONFERENCE CALL ON RARE DISEASE PR Newswire THOUSAND OAKS, Calif. , Feb. 19, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will host a webcasted call at 1:00 p.m. PT on Thursday, February 22, 2024 to discuss Rare Disease, its newly added fourth pilla...
2024-02-17 09:30:00 ET Get ahead of the market by subscribing to Seeking Alpha's Stocks to Watch, a preview of key events scheduled for the coming week. The newsletter keeps you informed of the biggest stories set to make headlines, including upcoming IPOs, investor days, earnings reports a...
2024-02-17 08:13:00 ET Amgen (NASDAQ: AMGN) is one of the largest drug manufacturers in the world, with a market cap of more than $150 billion. It pays a dividend, has been growing steadily over the years, and has many growth opportunities and blockbusters in its portfolio. It has a...
2024-02-16 15:12:17 ET Summary The narrow rally trend in 2023 is expected to continue in 2024, making overweighting profitable big-tech stocks a successful strategy. The best intersections of quality, growth, and value in the market exist in mega-cap tech land. Most other stoc...
2024-02-16 15:11:53 ET Summary I created a U.S. stock portfolio in mid-2023 that has outperformed with a 24% total return vs 17% for the S&P 500. I address valuation concerns for the U.S. market and include dividend growers and international stocks in the portfolio. The co...
2024-02-16 15:00:59 ET More on the markets SPY Pullback Triggers Sell Signal (Technical Analysis) SPY: Up 14 Weeks Out Of Last 15 - I'm Out SPY: Larger Treasury Issuances And Fewer Fed Cuts Are Not Priced In Investors retract capital from the fund market for ...
News, Short Squeeze, Breakout and More Instantly...
2024-07-18 10:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-15 07:58:00 ET Can a biotechnology company pay a generous dividend in 2024? The answer is definitely yes, as Amgen (NASDAQ: AMGN) is evidently unafraid to reward its loyal shareholders with quarterly cash payments. Just as importantly, Amgen is a recent revenue growe...
2024-07-14 06:30:00 ET Income investors don't have to settle for dividends that tread water. There are plenty of stocks to buy that offer growing dividends and are poised to keep the momentum going along with attractive dividend yields . Three Motley Fool contributors think they've ...